Caris Life Sciences
About Caris Life Sciences
Caris Life Sciences is a leading AI TechBio company and pioneer in precision medicine, dedicated to revolutionizing healthcare by providing physicians and patients with comprehensive, data-driven insights into disease. The company was founded on the belief that combining vast molecular information with robust data analytics can unlock the full potential of personalized medicine. Caris achieves this through advanced molecular profiling, utilizing Whole Exome and Whole Transcriptome Sequencing (WES/WTS) of both tissue and blood samples, alongside immunohistochemistry (IHC) of key proteins. [1, 2, 22, 26, 27]
Through the application of advanced artificial intelligence (AI) and machine learning algorithms, Caris has built one of the largest clinico-genomic databases globally. This extensive database and cognitive computing capability enable the analysis and unraveling of the molecular complexity of diseases, primarily focusing on cancer. The insights generated help clinicians navigate among potential therapies, identify novel treatment options, determine drugs unlikely to provide benefit (thereby avoiding unnecessary toxicities and costs), and match patients to appropriate clinical trials. [1, 2, 22, 26, 27]
While Caris has a primary focus on oncology, developing market-leading precision medicine tools that have aided over half a million cancer patients worldwide, its precision medicine approach extends to other disease areas. These include cardiology, neurology, and various metabolic conditions, demonstrating a broader vision for improving the human condition through molecular science and AI-driven solutions. [1, 2, 8, 25]
Focus Areas
Business Intelligence
| Key Investors | Braidwell, Perceptive Advisors, Woodline, Ghisallo Capital Management, Millennium Management, First Light Asset Management, Sixth Street, T. Rowe Price, Silver Lake, Fidelity Investments, Coatue, Neuberger Berman, Highland Capital Management, Columbia Threadneedle Investments, CPP Investments, Orbimed |
| Partnerships | Meaningful Insights Biotech Analytics (MiBA), Genentech, Ontada, Merck KGaA, Moderna, Incyte, Flatiron Health, UCSF Helen Diller Family Comprehensive Cancer Center |
| Acquisitions | Pharmatech, Inc. |
| Technology | AI and machine learning algorithms, proprietary AI analytics engine DEAN, comprehensive molecular profiling (Whole Exome Sequencing, Whole Transcriptome Sequencing, Whole Genome Sequencing, protein analysis, immunohistochemistry), large-scale clinico-genomic database, Caris Nanoverse™, Caris CODEai™ |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
For physicians, Caris Life Sciences offers unparalleled molecular insights to personalize cancer treatment. Utilize their comprehensive molecular profiling (tissue or liquid biopsy) to navigate therapy options, identify potentially beneficial treatments, avoid unnecessary toxicities and costs from ineffective drugs, and efficiently match patients to relevant clinical trials. Leverage their AI-driven predictive algorithms for deeper understanding of tumor biology and therapy response. Take advantage of their expert scientific and clinical support, including report interpretation and Medical Science Liaison assistance, to integrate precision medicine best practices into your patient care. Their EHR integrations can streamline your workflow for seamless access to critical patient data.
Caris Life Sciences offers EHR integrations to facilitate seamless access to molecular profiling results and patient data, enabling a more efficient and integrated precision medicine workflow within existing healthcare systems.
What the Web Says
Caris Life Sciences is a precision oncology company that utilizes advanced molecular profiling and AI to develop cancer diagnostics and guide treatment. The company's products, such as MI Cancer Seeku00ae and Caris Assureu2122, are designed to provide comprehensive molecular blueprints of tumors and track cancer with liquid biopsies. While patient testimonials highlight the life-changing impact of Caris's technology, employee reviews often point to significant issues within the company culture and management.
Overall: MixedStrengths
- Meaningful work in cancer research and precision oncology.
- Good pay for some positions.
- Extensive training for assays.
- Opportunities for molecular assay experience and potential for upward movement.
- Innovative use of AI for cancer detection and therapy selection.
- Strong employee retention with staff staying an average of 4.5 years.
Limitations
- Toxic company culture and favoritism.
- Poor and micromanaging leadership/management.
- Bad work-life balance and mandatory overtime.
- Disorganization, confusion, and constant shifts in processes without clear communication.
- Terrible benefits despite good pay in some instances.
- Repetitive job tasks with little room for advancement in some roles.
Based on reviews from: Indeed.com, Reddit, Zippia, PR Newswire, YouTube, TIKR.com
Last updated: 2026-07-24
Videos
News, demos, and interviews about Caris Life Sciences.
Videos load interactively. If none appear, search YouTube for Caris Life Sciences →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Caris Life Sciences.
Related Companies
Clarista is a healthcare AI company that focuses on building a “trust layer” for enterprise AI, particularly within regulated industries like healthcare and financial services. The company’s platform aims to address the challenges of data fragmentation, governance, and compliance that often hinder the successful implementation of AI projects in large organizations. Clarista’s technology unifies structured […]
HelloBooks.ai is an AI-powered accounting software company that aims to automate and simplify financial management for small businesses, freelancers, and accounting professionals. The platform utilizes generative AI to handle repetitive bookkeeping tasks such as transaction categorization, receipt capture, bank reconciliation, and report generation. It is designed to reduce manual data entry and improve accuracy, allowing […]
Vero, also known as Vero.ai, is an artificial intelligence company specifically designed to augment clinical workflows and improve patient care within the healthcare sector. Their primary focus is on leveraging AI to streamline administrative tasks, enhance diagnostic accuracy, and personalize treatment plans. By automating routine processes, Vero aims to free up healthcare professionals’ time, allowing […]
Ant Group, a global digital technology provider and operator of Alipay, has significantly expanded its focus into healthcare AI. The company recently upgraded its physician platform, Haodf for Doctor, into ‘AQ for Doctor,’ an AI-powered workstation designed to support physicians across various stages of clinical practice, including online consultations, patient management, clinical decision support, and […]
e4health is a healthcare consulting and services company that provides innovative solutions to hospitals, health systems, outpatient providers, and physician practices. The company focuses on addressing data, quality, and revenue challenges within the healthcare ecosystem. Their services are designed to streamline health information data and workflows, optimize coding, quality, and clinical documentation integrity processes, and […]
PayZen is a healthcare AI company dedicated to solving the healthcare affordability crisis for both patients and providers. The company’s AI-powered platform offers personalized, interest-free, and fee-free patient financing solutions, enabling patients to manage their medical bills through affordable payment plans tailored to their unique ability to pay. This approach aims to increase access to […]